Department of Nuclear Medicine, Changhai Hospital, Shanghai, China.
Clin Nucl Med. 2013 Mar;38(3):e118-24. doi: 10.1097/RLU.0b013e318270868a.
The aim of this study was to evaluate retrospectively (18)F-FDG PET/CT findings of solid pseudopapillary tumor of the pancreas (SPTP).
FDG PET/CT findings were reviewed in 8 patients with SPTP confirmed by pathology. Early PET/CT scans were performed 1 hour after FDG injection in all 8 patients. After an interval of 1 hour, delayed PET/CT scans were performed in 6 patients. All patients underwent enhanced CT and 4 patients underwent MRI.
A total of 8 tumors were detected in all 8 patients. CT and MRI findings included encapsulation (n = 2), solid and cystic components (n = 4), focal calcification (n = 7), and weak enhancement during the arterial phase on enhanced CT or MRI and increasing enhancement during the portal venous phase (n = 8). All the tumors showed increased FDG uptake. The mean SUVmax of all tumors was 8.9, with a high variability of SUVmax among lesions ranging from 2.5 to 29.1. The tumors (n = 6) with high cellularity had stronger FDG uptake, whereas the tumors (n = 2) with low cellularity had relatively low FDG uptake. The tumors (n = 6) with pancreatic parenchymal, vascular, or perineural invasions had intense FDG uptake, whereas the tumors (n = 2) without invasions had slight-to-moderate FDG uptake. Two tumors with relatively high proliferative index had very strong FDG uptake, whereas those (n = 6) with low proliferative index or negative Ki-67 staining result had relatively lower FDG uptake. On delayed FDG PET/CT images, The SUVmax of SPTP increased in 4 patients and slightly decreased in 2 patients.
CT or MRI demonstrated morphological features of SPTP and FDG PET/CT that reflected the histopathological composition of the tumors. FDG uptake of SPTP may be related to tumor cellularity, proliferative index, or histological malignancy. Familiarity with the morphological and functional imaging findings of SPTP may be helpful for correct diagnosis and appropriate treatment.
本研究旨在回顾性评估胰腺实性假乳头状瘤(SPTP)的 18F-FDG PET/CT 表现。
对 8 例经病理证实的 SPTP 患者的 FDG PET/CT 结果进行回顾性分析。所有 8 例患者均在 FDG 注射后 1 小时行早期 PET/CT 扫描,6 例患者在 1 小时后行延迟 PET/CT 扫描。所有患者均行增强 CT 检查,4 例患者行 MRI 检查。
8 例患者共检出 8 个肿瘤。CT 和 MRI 表现包括包膜(n=2)、实性和囊性成分(n=4)、局灶性钙化(n=7)、增强 CT 或 MRI 动脉期轻度强化和门静脉期强化增强(n=8)。所有肿瘤均显示 FDG 摄取增加。所有肿瘤的平均 SUVmax 为 8.9,病变之间 SUVmax 差异较大,范围为 2.5 至 29.1。细胞丰富的肿瘤(n=6)摄取 FDG 较多,而细胞含量低的肿瘤(n=2)摄取 FDG 较少。有胰腺实质、血管或神经周围侵犯的肿瘤(n=6)摄取 FDG 较多,而无侵犯的肿瘤(n=2)摄取 FDG 较少。2 个增殖指数较高的肿瘤摄取 FDG 非常强烈,而增殖指数较低或 Ki-67 染色结果阴性的肿瘤(n=6)摄取 FDG 较少。在延迟 FDG PET/CT 图像上,4 例患者的 SPTP SUVmax 增加,2 例患者的 SUVmax 略有下降。
CT 或 MRI 显示了 SPTP 的形态学特征,FDG PET/CT 反映了肿瘤的组织病理学组成。SPTP 的 FDG 摄取可能与肿瘤细胞密度、增殖指数或组织学恶性程度有关。熟悉 SPTP 的形态和功能成像表现可能有助于正确诊断和适当治疗。